IP Library › Granted Patent US 12,485,004
Granted Patent B2
US 12,485,004 · App. 17/086,511 · Granted Dec 2, 2025

Stents for prosthetic heart valves

Inventors: Gianfranco M. Pellegrini (Santa Rosa, CA); Mike Krivoruchko (Forestville, CA); Finn Rinne (Santa Rosa, CA); Matthew Rust (Windsor, CA)
Assignee: Medtronic, Inc.
A61F2/2418A61F2/2412A61F2/2433A61F2230/0054A61F2230/0067A61F2230/0078A61F2230/008A61F2250/0036A61F2250/0039
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,485,004
App. No.
17/086,511
Granted
Dec 2, 2025
Kind
B2
Abstract

A prosthetic valve including a wire frame having a generally tubular body portion, an interior area, a longitudinal axis, a first end comprising a plurality of crowns, and a second end comprising a greater number of crowns than the first end. The wire frame includes a plurality of adjacent rows of modified diamond-shaped structures extending between the first and second ends. The prosthetic valve further includes a valve structure that includes a plurality of leaflets and that is attached within the interior area of the wire frame.

Claims (55)

1 . A prosthetic valve comprising:

a stent frame having a radially collapsed configuration and a radially expanded configuration, the stent frame comprising:

a generally tubular body portion,

an interior area,

a longitudinal axis,

an inflow portion,

an outflow portion,

a central portion disposed between the inflow portion and the outflow portion,

a first row of first cells defining an inflow edge of the stent frame, wherein the first cells are generally diamond-shaped, and

a second row of second cells defining an outflow edge of the stent frame, each of the second cells being larger than each of the first cells, wherein the second cells are generally diamond-shaped,

wherein in the radially expanded configuration, the inflow portion has an inflow outer diameter, the central portion has a central outer diameter, and the outflow portion has an outflow outer diameter, wherein the inflow outer diameter and the central outer diameter are generally the same such that the inflow portion and the central portion are substantially cylindrical, and wherein the outflow outer diameter is larger than the inflow outer diameter and the central outer diameter,

wherein the first cells include proximal crowns at a proximal end thereof and the second cells include distal crowns at a distal end thereof, wherein the stent frame includes more proximal crowns than distal crowns; and

a tissue valve attached within the interior area of the stent frame, wherein the tissue valve is attached to the stent frame along a margin of attachment, wherein the margin of attachment is generally U-shaped and a proximal-most end of the margin of attachment is disposed within two rows of cells from the inflow edge of the stent frame.

2 . The prosthetic valve of claim 1 , further comprising a connector configured to couple the prosthetic valve to a delivery system, the connector extending from a distal crown of at least one of the second cells in a direction away from the inflow end, wherein the connector includes a post having a first end extending from the distal crown and a half-dome portion at a second end opposite the first end.

3 . The prosthetic valve of claim 1 , further comprising a connector configured to couple the prosthetic valve to a delivery system, the connector extending from a distal crown of at least one of the second cells in a direction away from the inflow end, wherein the connector includes a post having a first end extending from the distal crown and a tee portion at a second end opposite the first end.

4 . The prosthetic valve of claim 1 , wherein the stent frame includes exactly twice as many proximal crowns as distal crowns.

5 . The prosthetic valve of claim 1 , wherein the stent frame further includes a third row of third cells disposed between the first row of first cells and the second row of second cells.

6 . The prosthetic valve of claim 5 , wherein the stent frame further comprises a connector region between the first row of first cells and the third row of third cells.

7 . The prosthetic valve of claim 6 , wherein the connector region includes a radiopaque feature.

8 . The prosthetic valve of claim 6 , wherein the connector region includes peak-to-valley connectors connecting the first row to the third row.

9 . The prosthetic valve of claim 6 , wherein the connector region includes vertical wire portions connecting a peak of the first row of cells to a valley of the third row of cells.

10 . The prosthetic valve of claim 9 , wherein the connector region includes a radiopaque feature.

11 . The prosthetic valve of claim 1 , wherein the stent frame further includes at least two rows of diamond-shaped cells disposed between the first row of first cells and the second row of second cells.

12 . A prosthetic valve comprising:

a stent frame having a radially collapsed configuration and a radially expanded configuration, the stent frame comprising:

a generally tubular body portion,

an interior area,

a longitudinal axis,

an inflow portion,

an outflow portion,

a central portion disposed between the inflow portion and the outflow portion,

a first row of first cells defining an inflow edge of the stent frame, wherein the first cells are generally diamond-shaped,

a second row of second cells defining an outflow edge of the stent frame, each of the second cells being larger than each of the first cells, wherein the second cells are generally diamond-shaped,

a third row of third cells disposed between the first row of first cells and the second row of second cells, and

a connector region between the first row of first cells and the third row of third cells, wherein the connector region comprises wire portions parallel to the longitudinal axis of the stent frame,

wherein in the radially expanded configuration, the inflow portion has an inflow outer diameter, the central portion has a central outer diameter, and the outflow portion has an outflow outer diameter, wherein the inflow outer diameter and the central outer diameter are generally the same such that the inflow portion and the central portion are substantially cylindrical, and wherein the outflow outer diameter is larger than the inflow outer diameter and the central outer diameter, and

a tissue valve attached within the interior area of the stent frame, wherein the tissue valve is attached to the stent frame along a margin of attachment, wherein the margin of attachment is generally U-shaped and a proximal-most end of the margin of attachment is disposed within two rows of cells from the inflow edge of the stent frame.

13 . A prosthetic valve comprising:

a stent frame having a radially compressed configuration and a radially expanded configuration, the stent frame comprising:

a generally tubular body portion,

an interior area,

a longitudinal axis,

an inflow end,

an outflow end, and

a plurality of rows of a plurality of diamond-shaped cells, wherein the plurality of rows includes,

a first row of first cells defining the inflow end of the stent frame, the first cells including first valleys at the inflow end of the frame and first peaks distal of the first valleys,

a second row of second cells distal of the first row of first cells, the second cells including second valleys towards the inflow end and second peaks towards the outflow end,

a third row of third cells distal of the second row of second cells, the third cells including third valleys towards the inflow end and third peaks towards the outflow end, wherein the second row of second cells is disposed between the first row and the third row, and

a plurality of connectors, each of the connectors having a first end connected to one of the first peaks and a second end connected to one of the third valleys such that the first peaks are longitudinally spaced from the third valleys, wherein the second valleys are disposed circumferentially between the connectors; and

a valve structure attached within the interior area of the stent frame, the valve structure comprising a plurality of leaflets.

14 . The prosthetic valve of claim 13 , wherein each connector comprises a vertical wire portion.

15 . The prosthetic valve of claim 13 , wherein in the radially expanded configuration, the outflow end has an outflow outer diameter that is larger than an inflow outer diameter of the inflow end.

16 . The prosthetic valve of claim 15 , wherein the stent frame further includes a central portion between the inflow end and the outflow end, wherein in the radially expanded configuration, the central portion has a central outer diameter that is the same as the inflow outer diameter of the inflow end.

17 . The prosthetic valve of claim 16 , wherein the inflow end and the central portion comprise at least two rows of a plurality of diamond-shaped structures.

18 . The prosthetic valve of claim 13 , wherein the second valleys are distal of the first peaks.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2020
From: PELLEGRINI, GIANFRANCO M.; KRIVORUCHKO, MIKE; RINNE, FINN O.; RUST, MATTHEW J.
To: MEDTRONIC, INC.
Reel/Frame 054235/0801 →
Continuity (4)
Continuation 15281321 · Sep 30, 2016
Division 13071274 · Mar 24, 2011
Provisional Application 61317459 · Mar 25, 2010
Related Publication 20210077256A1 · Mar 18, 2021
References Cited (60)
US 3671979A · Moulopoulos · 1972 [cited by applicant]
US 4056854A · Boretos · 1977 [cited by applicant]
US 4994077A · Dobben · 1991 [cited by applicant]
US 5332402A · Teitelbaum · 1994 [cited by applicant]
US 5397351A · Pavcnik et al. · 1995 [cited by applicant]
US 5554185A · Block et al. · 1996 [cited by applicant]
US 5855601A · Bessler et al. · 1999 [cited by applicant]
US 6168614B1 · Andersen et al. · 2001 [cited by applicant]
US 7896915B2 · Guyenot et al. · 2011 [cited by applicant]
US 7972378B2 · Tabor · 2011 [cited by examiner]
US 8092520B2 · Quadri · 2012 [cited by examiner]
US 8313525B2 · Tuval et al. · 2012 [cited by applicant]
US 8398704B2 · Straubinger et al. · 2013 [cited by applicant]
US 8679174B2 · Ottma et al. · 2014 [cited by applicant]
US 8808366B2 · Braido · 2014 [cited by examiner]
US 8834564B2 · Tuval et al. · 2014 [cited by applicant]
US 9295551B2 · Straubinger et al. · 2016 [cited by applicant]
US 9532868B2 · Braido · 2017 [cited by examiner]
US 20030036791A1 · Bonhoeffer et al. · 2003 [cited by applicant]
US 20030149476A1 · Figulla · 2003 [cited by applicant]
US 20030149478A1 · Figulla et al. · 2003 [cited by applicant]
US 20030199963A1 · Tower et al. · 2003 [cited by applicant]
US 20030199971A1 · Tower et al. · 2003 [cited by applicant]
US 20040034411A1 · Quijano et al. · 2004 [cited by applicant]
US 20050137691A1 · Salahieh et al. · 2005 [cited by applicant]
US 20050283962A1 · Boudjemline · 2005 [cited by applicant]
US 20060259136A1 · Nguyen et al. · 2006 [cited by applicant]
US 20060265056A1 · Nguyen · 2006 [cited by examiner]
US 20070100440A1 · Figulla · 2007 [cited by applicant]
US 20080255661A1 · Straubinger et al. · 2008 [cited by applicant]
US 20090054976A1 · Tuval · 2009 [cited by examiner]
US 20090171447A1 · Von Segesser et al. · 2009 [cited by applicant]
US 20090216312A1 · Straubinger et al. · 2009 [cited by applicant]
US 20090287299A1 · Tabor et al. · 2009 [cited by applicant]
DE 19546692C2 · 2002 [cited by applicant]
DE 102005051849B4 · 2007 [cited by applicant]
WO 2001062189A1 · 2001 [cited by applicant]
WO 2004019825A1 · 2004 [cited by applicant]
WO 2004082527A2 · 2004 [cited by applicant]
WO 2006108090A2 · 2006 [cited by applicant]
WO 2006127756A2 · 2006 [cited by applicant]
WO 2006127765A1 · 2006 [cited by applicant]
WO 2007130537A1 · 2007 [cited by applicant]
WO 2009092782A1 · 2009 [cited by applicant]
WO 2009094188A2 · 2009 [cited by applicant]
WO 2010086460A1 · 2010 [cited by applicant]
WO 2010098857A1 · 2010 [cited by applicant]
EP Appln No. 16196563.7-1651, Extended European Search Report, dated May 12, 2017. [cited by applicant]
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J.… [cited by applicant]
Anderson, J. R., et al., “Transluminal Catheter Implantation of New Expandable Artificial Cardiac Valve”, EUR Heart J., 1990, 11: (Suppl) 224a. [cited by applicant]
Block P C, “Clinical and Hemodyamic Follow-Up After Percutaneous Aortic Valvuloplasty in the Elderly”, The American Journal of Cardiology, vol. 62, Oct. 1, 1998. [cited by applicant]
Bonhoeffer, et al, “Percutaneous Insertion of the Pulmonary Valve,” Journal of the American College of Cardiology (United States), May 15, 2002, pp. 1664-1669. [cited by applicant]
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816. [cited by applicant]
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-778. [cited by applicant]
Boudjemline, et al, “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs,” European Heart Journal (England), Jul. 2002, pp. 1045-1049. [cited by applicant]
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008. [cited by applicant]
Hilbert S. L., “Evaluation of Explanted Polyurethane Trileaflet Cardiac Valve Prosthesis”, J Thorac Cardiovascular Surgery, 1989; 94:419-29. [cited by applicant]
Kulkinski, D., “Future Horizons in Surgical Aortic Valve Replacement: Lessons Learned During the Early Stages of Developing a Transluminal Implantation Technique”, ASAIO J, 2004; 50:364-68. [cited by applicant]
EP communication dated Jul. 27, 2018 in corresponding EP Appln. No. 16 196 563.7. [cited by applicant]
EP Communication dated Dec. 12, 2020 in corresponding EP Appl. No. 20195818.8-1113. [cited by applicant]